Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SpikoGen phase II trial in healthy adults
NCT04944368Phase 2Completed
- Sponsor
- CinnaGen
- Start
- May 2021
- Primary completion
- Jul 2021
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of SpikoGen in coronavirus disease 2019 (COVID-19), sponsored by CinnaGen. Started May 2021; status: completed.
02
Drugs
SpikoGen
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04944368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04944368.